Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
Morocco · Delayed Price · Currency is MAD 1,349.00
+71.00 (5.56%)
At close: Jun 2, 2026
CBSE:PRO Income Statement
Financials in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 979.73 | 898.71 | 805.52 | 704.64 | 630.49 | |
Revenue Growth (YoY) | 9.01% | 11.57% | 14.32% | 11.76% | 10.00% |
Cost of Revenue | 554.98 | 508.82 | 446.27 | 332.17 | 299.96 |
Gross Profit | 424.75 | 389.89 | 359.24 | 372.47 | 330.53 |
Selling, General & Admin | 302.04 | 256.81 | 235.94 | 209.75 | 197.83 |
Other Operating Expenses | 31.92 | 26.88 | 22.64 | 28.6 | 27.77 |
Operating Expenses | 333.96 | 283.68 | 258.58 | 238.35 | 225.61 |
Operating Income | 90.79 | 106.21 | 100.66 | 134.12 | 104.92 |
Interest Expense | -11.44 | -10.15 | -4.64 | -1.42 | -0.31 |
Interest & Investment Income | 0.05 | - | 0.03 | 0.86 | 0.5 |
Currency Exchange Gain (Loss) | 12.48 | 1.93 | 2.94 | -9.92 | 1.35 |
Other Non Operating Income (Expenses) | 11.92 | 5.67 | 0.21 | -1.5 | 0.17 |
EBT Excluding Unusual Items | 103.81 | 103.66 | 99.21 | 122.14 | 106.63 |
Gain (Loss) on Sale of Assets | 0.53 | 0.13 | 0.19 | 1 | 0.03 |
Asset Writedown | -5 | -10.41 | - | -9.13 | - |
Other Unusual Items | -0.96 | -4.34 | -11.6 | 0.25 | -3.97 |
Pretax Income | 98.38 | 89.04 | 87.79 | 114.25 | 102.69 |
Income Tax Expense | 38.46 | 33.88 | 30.9 | 38.97 | 33.72 |
Net Income | 59.91 | 55.16 | 56.9 | 75.28 | 68.97 |
Net Income to Common | 59.91 | 55.16 | 56.9 | 75.28 | 68.97 |
Net Income Growth | 8.62% | -3.06% | -24.42% | 9.15% | 14.45% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 |
EPS (Basic) | 59.91 | 55.16 | 56.90 | 75.28 | 68.97 |
EPS (Diluted) | 59.91 | 55.16 | 56.90 | 75.28 | 68.97 |
EPS Growth | 8.62% | -3.06% | -24.42% | 9.15% | 14.45% |
Free Cash Flow | - | 153.31 | 147.18 | 70.32 | 215.53 |
Free Cash Flow Per Share | - | 153.31 | 147.18 | 70.32 | 215.53 |
Dividend Per Share | - | - | - | 40.000 | 40.000 |
Gross Margin | 43.35% | 43.38% | 44.60% | 52.86% | 52.42% |
Operating Margin | 9.27% | 11.82% | 12.50% | 19.03% | 16.64% |
Profit Margin | 6.12% | 6.14% | 7.06% | 10.68% | 10.94% |
Free Cash Flow Margin | - | 17.06% | 18.27% | 9.98% | 34.19% |
EBITDA | 107.9 | 123.32 | 112.68 | 143.25 | - |
EBITDA Margin | 11.01% | 13.72% | 13.99% | 20.33% | - |
D&A For EBITDA | 17.11 | 17.11 | 12.02 | 9.13 | - |
EBIT | 90.79 | 106.21 | 100.66 | 134.12 | 104.92 |
EBIT Margin | 9.27% | 11.82% | 12.50% | 19.03% | 16.64% |
Effective Tax Rate | 39.10% | 38.05% | 35.19% | 34.11% | 32.84% |
Revenue as Reported | 1,066 | 971.72 | 844.21 | 746.77 | 631.59 |